Log In
Print
BCIQ
Print
Print this Print this
 

PTX-9908

  Manage Alerts
Collapse Summary General Information
Company Pertinax Therapeutics Inc.
DescriptionStromal cell-derived factor-1 (SDF-1) analog
Molecular Target CXC chemokine receptor 4 (CXCR4) (NPY3R)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationLiver cancer
Indication DetailsTreat liver cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today